FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/12/047864 [Registered on: 02/12/2022] Trial Registered Prospectively
Last Modified On: 19/09/2023
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Single Arm Study 
Public Title of Study
Modification(s)  
Post Market Clinical Follow Up of Skanrays Fixed X-ray Systems (Clinical study to record the safety and performance data of Skanrays Fixed X-ray Systems in real world scenario) 
Scientific Title of Study
Modification(s)  
Prospective, post market, non - interventional observational, open label, single arm study to confirm the clinical safety and performance of Skanrays Fixed X-ray Systems 
Trial Acronym   
Secondary IDs if Any
Modification(s)  
Secondary ID  Identifier 
PLN-000777-0-20 Version 02 07 June 2023   Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Vikram Patil 
Designation  Associate Professor 
Affiliation  Department of Radio-diagnosis and Imaging JSS Hospital  
Address  Department of Radio-diagnosis and Imaging JSS Hospital Mysuru

Mysore
KARNATAKA
570004
India 
Phone  9886896511  
Fax    
Email  vikrampatil@jssuni.edu.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Vikram Patil 
Designation  Associate Professor 
Affiliation  Department of Radio-diagnosis and Imaging JSS Hospital  
Address  Department of Radio-diagnosis and Imaging JSS Hospital Mysuru

Mysore
KARNATAKA
570004
India 
Phone  9886896511  
Fax    
Email  vikrampatil@jssuni.edu.in  
 
Details of Contact Person
Public Query
 
Name  Vasundhara R  
Designation  Head - Regulatory Affairs 
Affiliation  Skanray Technologies Limited 
Address  Department of Regulatory Affairs, Skanray Technologies Limited Plot 15 16 17 Hebbal Industrial Area Mysore

Mysore
KARNATAKA
570016
India 
Phone  9844761818  
Fax    
Email  vasundhara.r@skanray.com  
 
Source of Monetary or Material Support
Modification(s)  
Skanray Technologies Limited, Plot 15-17, Hebbal Industrial Area, Mysore 570016  
 
Primary Sponsor  
Name  Skanray Technologies Limited 
Address  Plot 15-17, Skanray Technologies Limited, Hebbal Industrial Area, Mysore 
Type of Sponsor  Other [[Medical Device Manufacturer]] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Vikram Patil  JSS Hospital  Department of Radio-diagnosis and Imaging JSS Hospital Mahathma Gandhi Road Mysuru
Mysore
KARNATAKA 
9886896511

Vikrampatil@jssuni.edu.in 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 2  
Name of Committee  Approval Status 
Institutional Ethics Committee JSS Medical College and Hospital   Approved 
Institutional Ethics Committee JSS Medical College and Hospital   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: B||Imaging,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NA  NA 
Comparator Agent  NA  NA 
 
Inclusion Criteria  
Age From  1.00 Day(s)
Age To  99.00 Year(s)
Gender  Both 
Details  Male and female subjects of all age groups.
Subjects undergoing radiographic examination based on the advice of a physician.
Subjects or legally authorized representatives or guardians on behalf of the subject who are able and willing to provide written informed consent to participate in this clinical study.
 
 
ExclusionCriteria 
Details  Subjects who have not been advised for radiographic examination by a physician.
Pregnant or suspected to be pregnant based on the opinion of a physician.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome
Modification(s)  
Outcome  TimePoints 
Collection of feedback which includes user’s assessment of the overall safety and performance of the Skanrays Fixed X-ray Systems  Within 14 days after capturing the radiographic image  
 
Secondary Outcome
Modification(s)  
Outcome  TimePoints 
Collection of feedback from the radiographer on the safety, performance & usability of the Skanrays Fixed X-ray Systems.
 
Within 14 days after capturing the radiographic image  
 
Target Sample Size
Modification(s)  
Total Sample Size="250"
Sample Size from India="250" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Post Marketing Surveillance 
Date of First Enrollment (India)   08/12/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="4"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  
    Skanrays Fixed X-ray Systems are an advanced high frequency type X-ray system designed for superior image quality with a powerful generator and very low X-ray leakage radiation. The models of Skanrays Fixed X-ray Systems includes SKANRAD 400, SKANRAD 500 and SKANRAD 630.

    Intended for use in generating radiographic images of human anatomy in all general - purpose X-ray diagnostic procedures. It may be used in radiology departments, pediatrics, orthopedics and clinics. 

      The system has been designed for indoor usage. It is intended for qualified medical personnel or operators who have been trained in the use of X-ray equipment. Indicated for chest radiography for detectable infections, orthopaedic fractures and dislocations, digestive disorders studies, arthritis, spinal fractures  and pain management.

        This device is approved by CDSCO, AERB and BIS.  

          This clinical study is intended to collect feedback from user in the post market phase. 

           
          Close